ISBN: 9780199543434 - one political economy, one competitive strategy?: comparing pharmaceutical firms in germany, italy, and the uk (24 resultados)

Condición: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Hardcover. Condición: Very Good.

Condición: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Condición: New.

Condición: New.

Condición: As New. Unread book in perfect condition.

Condición: As New. Unread book in perfect condition.

Condición: New. In English.

Condición: New. This book examines how firms adapt to the pressures of increasing international competition by testing the arguments on 'strategy specialization' proposed in the competitiveness literature in general, and by contributors to the 'varieties of capitalism' debate in particular. It examines pharmaceutical firms in Germany, Italy, and the UK. Num Pages: 222 pages, numerous tables. BIC Classification: KCP; KJ; KJC; KNDP. Category: (P) Professional & Vocational. Dimension: 166 x 243 x 22. Weight in Grams: 486. . 2009. 1st Edition. Hardcover. . . . .…

Hardback. Condición: New. This book examines how firms adapt to the pressures of increasing international competition by testing the arguments on 'strategy specialization' proposed in the competitiveness literature in general, and by contributors to the 'varieties of capitalism' debate in particular. If different economies are characterized by distinct institutional arrangements, successful firms would be those that exploit the related comparative advantages and specialize in the competitive strategies facilitated by national institutions.One Political Economy, One Competitive Strategy? begins with an assessment of how many pharmaceutical firms in Germany, Italy, and the UK pursue strategies facilitated by national institutions governing the financial markets, antitrust activities, and the labour market. Quantitative analyses reveal that deviant firms, competing through institutionally unsupported strategies, outnumber conforming firms by far. Not only does this finding run counter to the expectations of the competitiveness literature, it brings up a whole new line of inquiry. How can firms compete through strategies that are not supported by national institutions? The book addresses this question and illustrates that firms do not necessarily exploit comparative institutional advantages, but that they can also circumvent institutional constraints. International markets and individual collaboration on a contractual basis allow firms to compete despite comparative institutional disadvantages. These findings suggest that trade liberalization does not lead to strategy specialization but to strategy diversification, depending on the inventiveness of entrepreneurs to develop individual approaches to compete.…

Hardcover. Condición: Brand New. 1st edition. 256 pages. 9.25x6.25x0.75 inches. In Stock.

Condición: New. This book examines how firms adapt to the pressures of increasing international competition by testing the arguments on 'strategy specialization' proposed in the competitiveness literature in general, and by contributors to the 'varieties of capitalism' debate in particular. It examines pharmaceutical firms in Germany, Italy, and the UK. Num Pages: 222 pages, numerous tables. BIC Classification: KCP; KJ; KJC; KNDP. Category: (P) Professional & Vocational. Dimension: 166 x 243 x 22. Weight in Grams: 486. . 2009. 1st Edition. Hardcover. . . . . Books ship from the US and Ireland.…

Hardback. Condición: New. This book examines how firms adapt to the pressures of increasing international competition by testing the arguments on 'strategy specialization' proposed in the competitiveness literature in general, and by contributors to the 'varieties of capitalism' debate in particular. If different economies are characterized by distinct institutional arrangements, successful firms would be those that exploit the related comparative advantages and specialize in the competitive strategies facilitated by national institutions.One Political Economy, One Competitive Strategy? begins with an assessment of how many pharmaceutical firms in Germany, Italy, and the UK pursue strategies facilitated by national institutions governing the financial markets, antitrust activities, and the labour market. Quantitative analyses reveal that deviant firms, competing through institutionally unsupported strategies, outnumber conforming firms by far. Not only does this finding run counter to the expectations of the competitiveness literature, it brings up a whole new line of inquiry. How can firms compete through strategies that are not supported by national institutions? The book addresses this question and illustrates that firms do not necessarily exploit comparative institutional advantages, but that they can also circumvent institutional constraints. International markets and individual collaboration on a contractual basis allow firms to compete despite comparative institutional disadvantages. These findings suggest that trade liberalization does not lead to strategy specialization but to strategy diversification, depending on the inventiveness of entrepreneurs to develop individual approaches to compete.…

Condición: new. Questo è un articolo print on demand.

Hardcover. Condición: new. Hardcover. This book examines how firms adapt to the pressures of increasing international competition by testing the arguments on 'strategy specialization' proposed in the competitiveness literature in general, and by contributors to the 'varieties of capitalism' debate in particular. If different economies are characterized by distinct institutional arrangements, successful firms would be those that exploit the related comparative advantages and specialize in the competitivestrategies facilitated by national institutions.One Political Economy, One Competitive Strategy? begins with an assessment of how many pharmaceutical firms in Germany, Italy, andthe UK pursue strategies facilitated by national institutions governing the financial markets, antitrust activities, and the labour market. Quantitative analyses reveal that deviant firms, competing through institutionally unsupported strategies, outnumber conforming firms by far. Not only does this finding run counter to the expectations of the competitiveness literature, it brings up a whole new line of inquiry. How can firms compete through strategies that are not supported by nationalinstitutions? The book addresses this question and illustrates that firms do not necessarily exploit comparative institutional advantages, but that they can also circumvent institutional constraints.International markets and individual collaboration on a contractual basis allow firms to compete despite comparative institutional disadvantages. These findings suggest that trade liberalization does not lead to strategy specialization but to strategy diversification, depending on the inventiveness of entrepreneurs to develop individual approaches to compete. This book examines how firms adapt to the pressures of increasing international competition by testing the arguments on 'strategy specialization' proposed in the competitiveness literature in general, and by contributors to the 'varieties of capitalism' debate in particular. It examines pharmaceutical firms in Germany, Italy, and the UK. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.…

Hardcover. Condición: new. Hardcover. This book examines how firms adapt to the pressures of increasing international competition by testing the arguments on 'strategy specialization' proposed in the competitiveness literature in general, and by contributors to the 'varieties of capitalism' debate in particular. If different economies are characterized by distinct institutional arrangements, successful firms would be those that exploit the related comparative advantages and specialize in the competitivestrategies facilitated by national institutions.One Political Economy, One Competitive Strategy? begins with an assessment of how many pharmaceutical firms in Germany, Italy, andthe UK pursue strategies facilitated by national institutions governing the financial markets, antitrust activities, and the labour market. Quantitative analyses reveal that deviant firms, competing through institutionally unsupported strategies, outnumber conforming firms by far. Not only does this finding run counter to the expectations of the competitiveness literature, it brings up a whole new line of inquiry. How can firms compete through strategies that are not supported by nationalinstitutions? The book addresses this question and illustrates that firms do not necessarily exploit comparative institutional advantages, but that they can also circumvent institutional constraints.International markets and individual collaboration on a contractual basis allow firms to compete despite comparative institutional disadvantages. These findings suggest that trade liberalization does not lead to strategy specialization but to strategy diversification, depending on the inventiveness of entrepreneurs to develop individual approaches to compete. This book examines how firms adapt to the pressures of increasing international competition by testing the arguments on 'strategy specialization' proposed in the competitiveness literature in general, and by contributors to the 'varieties of capitalism' debate in particular. It examines pharmaceutical firms in Germany, Italy, and the UK. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

HRD. Condición: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

HRD. Condición: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

Hardcover. Condición: new. Hardcover. This book examines how firms adapt to the pressures of increasing international competition by testing the arguments on 'strategy specialization' proposed in the competitiveness literature in general, and by contributors to the 'varieties of capitalism' debate in particular. If different economies are characterized by distinct institutional arrangements, successful firms would be those that exploit the related comparative advantages and specialize in the competitivestrategies facilitated by national institutions.One Political Economy, One Competitive Strategy? begins with an assessment of how many pharmaceutical firms in Germany, Italy, andthe UK pursue strategies facilitated by national institutions governing the financial markets, antitrust activities, and the labour market. Quantitative analyses reveal that deviant firms, competing through institutionally unsupported strategies, outnumber conforming firms by far. Not only does this finding run counter to the expectations of the competitiveness literature, it brings up a whole new line of inquiry. How can firms compete through strategies that are not supported by nationalinstitutions? The book addresses this question and illustrates that firms do not necessarily exploit comparative institutional advantages, but that they can also circumvent institutional constraints.International markets and individual collaboration on a contractual basis allow firms to compete despite comparative institutional disadvantages. These findings suggest that trade liberalization does not lead to strategy specialization but to strategy diversification, depending on the inventiveness of entrepreneurs to develop individual approaches to compete. This book examines how firms adapt to the pressures of increasing international competition by testing the arguments on 'strategy specialization' proposed in the competitiveness literature in general, and by contributors to the 'varieties of capitalism' debate in particular. It examines pharmaceutical firms in Germany, Italy, and the UK. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…

Buch. Condición: Neu. One Political Economy, One Competitive Strategy? | Comparing Pharmaceutical Firms in Germany, Italy, and the UK | Andrea M. Herrmann | Buch | Gebunden | Englisch | 2008 | OUP Oxford | EAN 9780199543434 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand.…

Condición: New. Print on Demand pp. 222.

Buch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - This book examines how firms adapt to the pressures of increasing international competition by testing the arguments on 'strategy specialization' proposed in the competitiveness literature in general, and by contributors to the 'varieties of capitalism' debate in particular. If different economies are characterized by distinct institutional arrangements, successful firms would be those that exploit the related comparative advantages and specialize in the competitive strategies facilitated by national institutions.One Political Economy, One Competitive Strategy begins with an assessment of how many pharmaceutical firms in Germany, Italy, and the UK pursue strategies facilitated by national institutions governing the financial markets, antitrust activities, and the labour market. Quantitative analyses reveal that deviant firms, competing through institutionally unsupported strategies, outnumber conforming firms by far. Not only does this finding run counter to the expectations of the competitiveness literature, it brings up a whole new line of inquiry. How can firms compete through strategies that are not supported by national institutions The book addresses this question and illustrates that firms do not necessarily exploit comparative institutional advantages, but that they can also circumvent institutional constraints. International markets and individual collaboration on a contractual basis allow firms to compete despite comparative institutional disadvantages. These findings suggest that trade liberalization does not lead to strategy specialization but to strategy diversification, depending on the inventiveness of entrepreneurs to develop individual approaches to compete.…

Condición: New. Print on Demand pp. 222 52:B&W 6.14 x 9.21in or 234 x 156mm (Royal 8vo) Case Laminate on White w/Gloss Lam.

Condición: New. PRINT ON DEMAND pp. 222.